Bank Hapoalim BM Trims Stake in UiPath Inc. (NYSE:PATH)

Bank Hapoalim BM trimmed its position in UiPath Inc. (NYSE:PATH) by 9.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,899 shares of the healthcare company’s stock after selling 7,788 shares during the quarter. Bank Hapoalim BM’s holdings in UiPath were worth $946,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in PATH. Future Financial Wealth Managment LLC bought a new position in shares of UiPath during the third quarter valued at approximately $26,000. JTC Employer Solutions Trustee Ltd purchased a new position in shares of UiPath in the 3rd quarter valued at $26,000. ORG Partners LLC increased its holdings in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after acquiring an additional 1,112 shares during the period. Hantz Financial Services Inc. bought a new position in shares of UiPath in the 2nd quarter worth $28,000. Finally, Redwood Wealth Management Group LLC bought a new stake in UiPath during the second quarter valued at about $43,000. Institutional investors own 62.50% of the company’s stock.

UiPath Stock Up 0.1 %

Shares of NYSE:PATH traded up $0.01 during midday trading on Thursday, reaching $12.62. The company’s stock had a trading volume of 474,051 shares, compared to its average volume of 9,577,778. The firm has a market capitalization of $6.94 billion, a PE ratio of -63.00 and a beta of 0.88. The stock has a fifty day moving average of $12.53 and a 200 day moving average of $13.92. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The business had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. During the same quarter last year, the business posted ($0.09) EPS. The company’s revenue was up 10.0% on a year-over-year basis. Sell-side analysts anticipate that UiPath Inc. will post -0.23 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several analysts have commented on PATH shares. BMO Capital Markets increased their price target on shares of UiPath from $14.00 to $15.00 and gave the company a “market perform” rating in a research report on Friday, September 6th. Needham & Company LLC reissued a “hold” rating on shares of UiPath in a research report on Wednesday, October 23rd. Bank of America lifted their price target on shares of UiPath from $16.00 to $18.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Wells Fargo & Company decreased their price objective on UiPath from $15.00 to $13.00 and set an “equal weight” rating for the company in a report on Wednesday, October 23rd. Finally, JPMorgan Chase & Co. dropped their target price on UiPath from $19.00 to $17.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. Sixteen equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $17.47.

Insider Activity at UiPath

In other news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total transaction of $575,388.97. Following the sale, the chief financial officer now directly owns 849,917 shares of the company’s stock, valued at $10,258,498.19. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 22.37% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.